A structured review of health utility measures and elicitation in advanced/metastatic breast cancer

por Hao, Yanni, Wolfram, Verena, Cook, Jennifer
Publicado 2016

Factors associated with medication interruption among outpatients with severe mental illness exposed to COVID-19

por Jiao, Jian, Ji, Yuanyi, Ren, Hua, Hao, Yanni, Shen, Xiaoling, Dong, Zaiquan
Publicado 2023

Estimation of Total Costs in Pediatric and Young Adult Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia Receiving Tisagenlecleucel from a U.S. Hospital’s Perspecti...

por Yang, Hongbo, Hao, Yanni, Qi, Cynthia Z., Chai, Xinglei, Wu, Eric Q.
Publicado 2020

Survival, healthcare resource use and costs among stage IV ER + breast cancer patients not receiving HER2 targeted therapy: a retrospective analysis of linked SEER-Medicare data...

por Lang, Kathleen, Huang, Huan, Sasane, Medha, Federico Paly, Victoria, Hao, Yanni, Menzin, Joseph
Publicado 2014

Gut microbiome: A potential indicator for predicting treatment outcomes in major depressive disorder

por Dong, Zaiquan, Shen, Xiaoling, Hao, Yanni, Li, Jin, Xu, Haizhen, Yin, Li, Kuang, Weihong
Publicado 2022

Healthcare Resource Use and Expenditures among Metastatic Breast Cancer Patients Treated with HER2-Targeted Agents

por Meyer, Nicole, Hao, Yanni, Song, Xue, Shi, Nianwen, Johnson, William, Willemann Rogerio, Jaqueline, Yardley, Denise A.
Publicado 2014

Everolimus-Based Therapy versus Chemotherapy among Patients with HR+/HER2− Metastatic Breast Cancer: Comparative Effectiveness from a Chart Review Study

por Li, Nanxin, Hao, Yanni, Xie, Jipan, Lin, Peggy L., Koo, Valerie, Ohashi, Erika, Wu, Eric Q.
Publicado 2015

Clinical Outcomes with First-line Endocrine Therapy or Chemotherapy in Postmenopausal HR+/HER2− Metastatic Breast Cancer

por Song, Yan, Hao, Yanni, Macalalad, Alexander R., Lin, Peggy L., Signorovitch, James E., Wu, Eric Q.
Publicado 2015

Clinical outcomes among HR+/HER2− metastatic breast cancer patients with multiple metastatic sites: a chart review study in the US

por Xie, Jipan, Hao, Yanni, Li, Nanxin, Lin, Peggy L., Ohashi, Erika, Koo, Valerie, Wu, Eric Q.
Publicado 2015

Knockdown of Phospholipase Cɛ (PLCɛ) Inhibits Cell Proliferation via Phosphatase and Tensin Homolog Deleted on Chromosome 10 (PTEN)/AKT Signaling Pathway in Human Prostate Cancer

por Wang, Xiao, Fan, Yanru, Du, Zhongbo, Fan, Jiaxin, Hao, Yanni, Wang, Jinhua, Wu, Xiaohou, Luo, Chunli
Publicado 2018

PLCε promotes urinary bladder cancer cells proliferation through STAT3/LDHA pathway-mediated glycolysis

por Cheng, Honglin, Hao, Yanni, Gao, Yingying, He, Yunfeng, Luo, Chunli, Sun, Wei, Yuan, Mengjuan, Wu, Xiaohou
Publicado 2019

Gut Microbiome: A Potential Indicator for Differential Diagnosis of Major Depressive Disorder and General Anxiety Disorder

por Dong, Zaiquan, Shen, Xiaoling, Hao, Yanni, Li, Jin, Li, Haoran, Xu, Haizheng, Yin, Li, Kuang, Weihong
Publicado 2021

Neferine alleviates chronic stress-induced depression by regulating monoamine neurotransmitter secretion and gut microbiota structure

por Dong, Zaiquan, Xie, Qinglian, Xu, Feiyu, Shen, Xiaoling, Hao, Yanni, Li, Jin, Xu, Haizhen, Peng, Qiang, Kuang, Weihong
Publicado 2022

Physician experiences and preferences in the treatment of HR+/HER2− metastatic breast cancer in the United States: a physician survey

por Lin, Peggy L., Hao, Yanni, Xie, Jipan, Li, Nanxin, Zhong, Yichen, Zhou, Zhou, Signorovitch, James E., Wu, Eric Q.
Publicado 2015

Patient-Reported Outcomes in Metastatic Breast Cancer: A Review of Industry-Sponsored Clinical Trials

por Krohe, Meaghan, Hao, Yanni, Lamoureux, Roger E., Galipeau, Nina, Globe, Denise, Foley, Catherine, Mazar, Iyar, Solomon, Jeffrey, Shields, Alan L.
Publicado 2016

Negative regulation of tumor-infiltrating NK cell in clear cell renal cell carcinoma patients through the exosomal pathway

por Xia, Yang, Zhang, Qiongfang, Zhen, Quan, Zhao, Yan, Liu, Nanjing, Li, Ting, Hao, Yanni, Zhang, Yao, Luo, Chunli, Wu, Xiaohou
Publicado 2017

Long noncoding RNA HOTAIR regulates the invasion and metastasis of prostate cancer by targeting hepaCAM

por Li, Ting, Liu, Nanjing, Gao, Yingying, Quan, Zhen, Hao, Yanni, Yu, Chaowen, Li, Luo, Yuan, Mengjuan, Niu, Lingfang, Luo, Chunli, Wu, Xiaohou
Publicado 2020

HepaCAM inhibits the malignant behavior of castration-resistant prostate cancer cells by downregulating Notch signaling and PF-3084014 (a γ-secretase inhibitor) partly reverses the...

por Du, Zhongbo, Li, Luo, Sun, Wei, Wang, Xiao, Zhang, Yao, Chen, Zhixiong, Yuan, Mengjuan, Quan, Zhen, Liu, Nanjing, Hao, Yanni, Li, Ting, Wang, Jinhua, Luo, Chunli, Wu, Xiaohou
Publicado 2018